Abaxis Inc. has a market cap of $616.5 million; its shares were traded at around $28.44 with a P/E ratio of 49.9 and P/S ratio of 4.3. Abaxis Inc. had an annual average earning growth of 32.8% over the past 10 years. GuruFocus rated Abaxis Inc. the business predictability rank of 3-star.
CFO Recent Trades:
- CFO and VP of Finance Alberto Santa Ines sold 15,000 shares of ABAX stock on 11/30/2011 at the average price of 25.88. Alberto Santa Ines owns at least 72,569 shares after this. The price of the stock has increased by 9.89% since.
This is the insider trade history vs. stock price of ABAX. For the complete insider trading history of ABAX, click here.
Directors and Officers Recent Trades:
- VP-Sales & Marketing,Medical Brenton Hanlon sold 2,900 shares of ABAX stock on 12/01/2011 at the average price of 27.84. Brenton Hanlon owns at least 5,133 shares after this. The price of the stock has increased by 2.16% since.
- Managing Director-Europe Achim Henkel sold 5,000 shares of ABAX stock on 11/15/2011 at the average price of 27.5. Achim Henkel owns at least 14,750 shares after this. The price of the stock has increased by 3.42% since.
- VP of Govt Affairs & Pac Rim Vladimir Ostoich sold 10,000 shares of ABAX stock on 10/28/2011 at the average price of 29.01. Vladimir Ostoich owns at least 382,313 shares after this. The price of the stock has decreased by 1.96% since.
- VP-Sales & Mktg, Animal Health Martin Mulroy sold 2,374 shares of ABAX stock on 10/26/2011 at the average price of 28.67. Martin Mulroy owns at least 24,765 shares after this. The price of the stock has decreased by 0.8% since.
For the complete insider trading history of ABAX, click here.







